BioSig Technologies Raises $10M Via Equity Issued At $4/Share
BioSig Technologies Inc (NASDAQ:BSGM) has priced its previously announced underwritten public offering of 2.5 million shares at $4.00 per share,…
BioSig Announces Pricing of Public Offering Of 2.5M Shares Of Common Stock At $4/Share
BioSig Technologies, Inc. (NASDAQ:BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal
The Daily Biotech Pulse: Iterum’s Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 1)
A Peek Into The Markets: US Stock Futures Edge Higher; All Eyes On Jobs Report
Pre-open movers
U.S. stock futures traded slightly higher in early pre-market trade ahead of all important jobs report. The Dow Jones jumped more than 100 points on Wednesday, while the S&P 500 registered another record closing high in the earlier session.
BioSig Completes 1,000 Patient Cases and Expects 1,500 more at the end of 2021
According to recent reports, the global electroceuticals/bioelectric medicine market is currently worth $16.8 billion and is projected to reach $21.5 billion by
BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology
The Company recently increased its procedural volume targets due to accelerated technology usage
BioSig expands its commercial team to target technology adoption across three strategic regions
BioSig Says Completes 1000 Patient Cases With Its Signal Processing System For Electrophysiology
BioSig Technologies, Inc. (NASDAQ:BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal